Anthony Do is a Senior Scientist in In Vivo Preclinical Pharmacology at Eli Lilly, a position they have held since 2022. Prior to this, they worked at Charles River Laboratories on the Corporate Response Team, performing contract work and training new hires from 2019 to 2021, and served as a Research Animal Specialist at Mass General Hospital from 2015 to 2019. Anthony is currently an MBA candidate at Boston University, expected to graduate in 2026.
This person is not in any teams
This person is not in any offices